| Regulatory Rapporteur January 2020 | MEMBERS |
| A review of imminent changes in the European regulatory landscape | MEMBERS |
| CMC challenges and opportunities presented by accelerated development | MEMBERS |
| Repositioning: old drugs, new tricks | MEMBERS |
| Drug repurposing – an avenue for rare disease patient entrepreneurs? | MEMBERS |
| Tasked with seeking better lives for patients with rare diseases | MEMBERS |